DURING THE LAST 5 years (September 1975 to August 1980 17 patients with Hodgkin's disease (HD) have had a staging laparotomy (SL) under the care of one surgeon (J-C.G.) within 2 months of the completion of a variable number of courses of chemotherapy, given as initial treatment after diagnosis.
I'ATIENTS
The indication.s for the initial chemiotherapy are shown in Table 1 , and w%Nere usually that laparotomy was considered hazardous in view of extensive mediastinal disease. Laparotomy was thus postponed until the patient was considered to be in clinical remission. One patient, however underwvent laparotom.y before he was thought There are however a number of objections to this argument. First of all, combination chemotherapy may be so effective in eradicating intra-abdominal disease, making the incidence of positive SL so low as to discourage the clinician from continuing to refer patients for this essentially diagnostic procedure.
Secondly, and more importantly, patients with positive SL may not have their management altered in consequence. For example, a patient with residual disease in his spleen but an otherwise normal SL might be considered to require further chemotherapy, but there is no evidence that this would be a better policy than simply waiting for clinical evidence of relapse before initiating further treatment. (The patient in this series with a positive spleen received no further chemotherapy postoperatively and remains disease-free after 4 years.) Or a patient with residual disease in the liver might be considered to require further chemotherapy but, again, there is no evidence that this would be a better policy than simply waiting for clinical evidence of relapse. Or patients with histologically involved nodes might be considered to require radiotherapy, but bipedal lymphography can assess iliac and lower para-aortic nodes, and if follow-up plain abdominal films are taken at regular intervals an accurate assessment of response to treatment can be made.
Computerized tomography is also playing a more important role in the assessment of intra-abdominal nodes, and laparotomy often yields no additional useful information on nodal status. (Tubiana et al., 1979) . Laparotomy and splenectomy however may still be necessary in patients with hypersplenism.
The same arguments apply to the suggestion that SL be reserved for patients with evidence of relapsed disease following chemotherapy. Most patients relapse with disease outside the abdomen, and the treatment of relapse is usually independent of any possible laparotomy findings. Five patients in this series have died, 2 of widely disseminated disease and 3 of mediastinal disease, and laparotomy at the time of relapse for these patients would have been hazardous as well as irrelevant.
Staging laparotomy should probably be avoided after initial chemotherapy. Residual disease in iliac and lower paraaortic nodes can be assessed by lymphography, and perhaps by computerized tomography. The likelihood of finding residual liver disease is small, and there is no reason to believe that treating such residual disease would in fact improve survival. 
